Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Shares, without par value
-
Shares outstanding
-
193,679,354
-
Total 13F shares
-
118,168,575
-
Share change
-
+25,056
-
Total reported value
-
$536,370,600
-
Put/Call ratio
-
27%
-
Price per share
-
$4.54
-
Number of holders
-
166
-
Value change
-
+$2,488,410
-
Number of buys
-
70
-
Number of sells
-
70
Institutional Holders of Arbutus Biopharma Corp - Common Shares, without par value (ABUS) as of Q3 2025
As of 30 Sep 2025,
Arbutus Biopharma Corp - Common Shares, without par value (ABUS) was held by
166 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
118,168,575 shares.
The largest 10 holders included
MORGAN STANLEY, Whitefort Capital Management, LP, BlackRock, Inc., Two Seas Capital LP, VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, ADAR1 Capital Management, LLC, and GOLDMAN SACHS GROUP INC.
This page lists
166
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.